Evonik Industries (EVK) Given a €29.00 Price Target by UBS Group Analysts
UBS Group set a €29.00 ($33.72) price target on Evonik Industries (FRA:EVK) in a report issued on Monday morning, www.boersen-zeitung.de reports. The brokerage currently has a sell rating on the stock.
Several other analysts also recently issued reports on EVK. Baader Bank set a €40.00 ($46.51) price target on shares of Evonik Industries and gave the company a buy rating in a report on Tuesday, May 29th. Nord/LB set a €32.00 ($37.21) price objective on shares of Evonik Industries and gave the company a neutral rating in a research report on Tuesday, May 29th. Goldman Sachs Group set a €32.00 ($37.21) price objective on shares of Evonik Industries and gave the company a neutral rating in a research report on Tuesday, June 5th. Warburg Research set a €38.00 ($44.19) price objective on shares of Evonik Industries and gave the company a buy rating in a research report on Tuesday, June 12th. Finally, DZ Bank reissued a neutral rating on shares of Evonik Industries in a research report on Tuesday, June 12th. Four analysts have rated the stock with a sell rating, six have issued a hold rating and twelve have issued a buy rating to the company. The company has a consensus rating of Hold and an average price target of €34.80 ($40.47).
Shares of FRA EVK opened at €31.42 ($36.53) on Monday. Evonik Industries has a 12-month low of €26.78 ($31.14) and a 12-month high of €32.97 ($38.34).
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
See Also: Google Finance Portfolio Workaround
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.